CARDIAC AND HEMODYNAMIC-EFFECTS OF DILTIAZEM DURING EXERCISE-INDUCED MYOCARDIAL DYSFUNCTION IN DOGS

被引:1
|
作者
GROHS, JG [1 ]
FISCHER, G [1 ]
RABERGER, G [1 ]
机构
[1] UNIV VIENNA,INST PHARMAKOL,ABT HERZ KREISLAUF PHARMAKOL,WAHRINGERSTR 13A,A-1090 VIENNA,AUSTRIA
关键词
Diltiazem; Dogs; Exercise; Hemodynamics; Regional myocardial dysfunction;
D O I
10.1097/00005344-199008000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of diltiazem were tested in chronically instrumented dogs in a model of exercise-induced myocardial dysfunction. Since various bradycardic agents have beneficial effects on myocardial function during ischemia, it was of interest to find out how a decrease in afterload, possibly combined with a decrease in myocardial oxygen demand, influences dysfunction. Therefore, diltiazem (1 mg/kg i.v.) was tested during critical stenosis of the circumflex branch of the left coronary artery, which led to exercise-induced myocardial dysfunction. At rest, diltiazem causes a reflex increase in heart rate. During exercise, a decrease in heart rate and hence in myocardial oxygen demand was neutralized by a decrease in arterial blood pressure and hence a lowered myocardial perfusion pressure. Therefore, systolic shortening in the ischemic area improved neither at rest nor during exercise after diltiazem. © 1990 Raven Press, Ltd., New York.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] LONG-TERM HEMODYNAMIC-EFFECTS OF AMLODIPINE AT REST AND DURING EXERCISE IN ESSENTIAL-HYPERTENSION
    LUNDJOHANSEN, P
    OMVIK, P
    WHITE, W
    DIGRANES, O
    HELLAND, B
    JORDAL, O
    STRAY, T
    CARDIOLOGY, 1992, 80 : 37 - 45
  • [22] LONG-TERM HEMODYNAMIC-EFFECTS OF SUSTAINED-RELEASE TRIMAZOSIN AT REST AND DURING EXERCISE IN ESSENTIAL-HYPERTENSION
    OMVIK, P
    LUNDJOHANSEN, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (02) : 131 - 134
  • [23] Myocardial inefficiency is an early indicator of exercise-induced myocardial fatigue
    Erevik, Christine Bjorkvik
    Kleiven, Oyunn
    Froysa, Vidar
    Bjorkavoll-Bergseth, Magnus
    Chivulescu, Monica
    Klaeboe, Lars Gunnar
    Dejgaard, Lars
    Auestad, Bjorn
    Skadberg, Oyvind
    Melberg, Tor
    Urheim, Stig
    Haugaa, Kristina
    Edvardsen, Thor
    Orn, Stein
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [24] Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy
    Ikeda, Hiroyuki
    Shiojima, Ichiro
    Ozasa, Yukako
    Yoshida, Masashi
    Holzenberger, Martin
    Kahn, C. Ronald
    Walsh, Kenneth
    Igarashi, Takashi
    Abel, E. Dale
    Komuro, Issei
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (05) : 664 - 675
  • [25] Lack of effects of the Na+/H+ exchanger inhibitor, cariporide against myocardial stunning in exercise-induced ischemia in dogs
    de Curzon, OP
    Ghaleh, B
    Giudicelli, JF
    Berdeaux, A
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1998, 12 (06) : 646 - 648
  • [26] SYSTEMIC AND CORONARY HEMODYNAMIC-EFFECTS OF REPETITIVE COCAINE ADMINISTRATION IN CONSCIOUS DOGS
    PAGEL, PS
    TESSMER, JP
    WARLTIER, DC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (03) : 443 - 453
  • [27] Metabolic Mechanisms of Exercise-Induced Cardiac Remodeling
    Fulghum, Kyle
    Hill, Bradford G.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [28] Intermittent Diet in Exercise-Induced Cardiac Remodeling
    Pacagnelli, Francis Lopes
    Aguiar, Andreo Fernando
    Engel, Leticia Estevam
    Bongiovani, Antonio Claudio
    Gomes, Mariana Janini
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (02) : 194 - 196
  • [29] Molecular Aspects of Exercise-induced Cardiac Remodeling
    Bernardo, Bianca C.
    McMullen, Julie R.
    CARDIOLOGY CLINICS, 2016, 34 (04) : 515 - +
  • [30] LONG-TERM HEMODYNAMIC-EFFECTS AT REST AND DURING EXERCISE OF NEWER ANTIHYPERTENSIVE AGENTS AND SALT RESTRICTION IN ESSENTIAL-HYPERTENSION - REVIEW OF EPANOLOL, DOXAZOSIN, AMLODIPINE, FELODIPINE, DILTIAZEM, LISINOPRIL, DILEVALOL, CARVEDILOL, AND KETANSERIN
    OMVIK, P
    LUNDJOHANSEN, P
    CARDIOVASCULAR DRUGS AND THERAPY, 1993, 7 (02) : 193 - 206